Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 12, 20261,338 studies indexed

September 2026

Added to Dediabetes Sep 9, 2026RCTs

Diabetes and PCI Linked to Higher 10-Year Mortality

This study examined long-term outcomes in patients with left main coronary artery disease and diabetes undergoing PCI, revealing significant mortality differences based on diabetes treatment.

Interventions
Percutaneous coronary intervention (PCI)
Outcomes
All-cause mortalityCardiac deathCoronary artery bypass graft surgery+4 more
Added to Dediabetes Sep 9, 2026RCTs

Anagliptin improves glycaemic control in type 2 diabetes patients

This study evaluated the efficacy and safety of anagliptin in patients with type 2 diabetes who were inadequately controlled on insulin and metformin, finding a significant reduction in HbA1c levels.

Interventions
Anagliptin 100 mg twice daily
Outcomes
BMIBlood glucoseBody weight+6 more
Added to Dediabetes Sep 9, 2026RCTs

Low-GI Diet Improves Glycemic Control in High-Risk Adults

This study identified differential glycemic responders among adults at elevated risk of Type 2 diabetes through a randomized controlled trial comparing high and low-glycemic index diets.

Interventions
High-Glycemic Index DietLow glycemic index treatment (LGIT)
Outcomes
Blood glucoseHbA1cInsulin sensitivity+1 more
Added to Dediabetes Sep 9, 2026RCTs

SGLT2 inhibitors improve glycemic control in hospitalized T2DM patients.

This study evaluated the impact of adding SGLT2 inhibitors to basal bolus therapy in hospitalized patients with type 2 diabetes, finding improved glycemic control.

Interventions
Basal bolus therapyBasal bolus therapy with empagliflozin
Outcomes
Change in ketone body levels after combination therapyDaily glucose averageTime above range+3 more
Added to Dediabetes Sep 9, 2026RCTs

Higher TI Dosing Needed for Effective Glucose Management

This study evaluated the dosing patterns of Technosphere insulin in adults with Type 1 diabetes, finding significant increases in total daily doses over 30 weeks.

Interventions
Insulin degludec
Outcomes
Percentage of participants increasing TI dose by >4 U at week 17Percentage of participants increasing TI dose by >4 U at week 30Reduction in Hemoglobin A1C levels+3 more
Added to Dediabetes Sep 9, 2026RCTs

CMNT diet may maintain diabetes remission for three years

This study investigated the effects of a Chinese Medical Nutrition Therapy (CMNT) diet on type 2 diabetes remission, finding significant improvements in diabetes-related outcomes.

Interventions
Chinese Medical Nutrition Therapy (CMNT) diet intervention
Outcomes
All-cause mortalityBody weightComplications+5 more
Added to Dediabetes Sep 9, 2026RCTs

METS-IR improves cardiovascular risk prediction in type 2 diabetes.

The study investigated METS-IR as a predictive biomarker for cardiovascular risk in patients with type 2 diabetes, finding significant associations with various adverse outcomes.

Interventions
METS-IR monitoring
Outcomes
All-cause mortalityCardiovascular deathIncidence heart disease+2 more
Added to Dediabetes Sep 9, 2026RCTs

Saxagliptin may maintain beta-cell function in type 1 diabetes

This study evaluated saxagliptin as an adjunct to insulin therapy in type 1 diabetes. It found no significant differences in glycemic control between the two treatment groups.

Interventions
Insulin onlySaxagliptin plus insulin
Outcomes
C-peptideHbA1cInsulin dosage per weight (unit/kg/day)+1 more
Added to Dediabetes Sep 9, 2026RCTs

Empagliflozin improves symptoms in diabetic neuropathy

The study investigated the effects of empagliflozin on glycaemic control and neuropathic symptoms in patients with type 2 diabetes and peripheral neuropathy, showing significant improvements in several key outcomes.

Interventions
Empagliflozin
Outcomes
AmplitudeChange in Michigan Neuropathy Screening Instrument scoreEstimated glomerular filtration rate+5 more

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.